← Eichor
Study identifier: NCT05911503 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

Condition: Cytomegalovirus Retinitis · Ganciclovir Eye Drops  ·  Sponsor: Tianjin Medical University

PhaseEARLY_Phase 1
Planned participants15
Who can joinAll sexes, 2 Years to 80 Years
Healthy volunteersNo

About this study

Clinical study of high concentration ganciclovir eye drops in the treatment of cytomegalovirus retinitis

This description comes directly from the study's public registry record.

Talk to the study team

xiaomin Zhang  ·  +8613920023990  ·  xiaomzh@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tianjin Medical University Eye HospitalTianjin, Tianjin Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05911503